IP Library Patent Application 15173159
Patent Application
App. No. 15/173,159

METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/173,159
Abstract

The present invention discloses, inter alia, methods for labeling a target protein with an SHG-active probe for detection by second harmonic or sum-frequency generation in order to identify agents which bind to an allosteric site on the target protein thereby altering its structural conformation

Claims (38)

1 - 79 . (canceled)

80 . A kit comprising:

one or more of:

a. one or more SHG or SFG-active labels for conjugation to a target protein;

b. one or more reagents for labeling proteins with SHG or SFG-active labels;

c. one or more surfaces for binding a target protein;

d. one or more co-factors necessary for target protein functionality;

e. one or more peptides and/or proteins known to bind to one or more target proteins;

f. one or more antibodies known to bind to one or more target proteins; and

g. one or more components for introducing SHG- or SFG-active unnatural amino acid (UAA) labels into proteins; and

one or more signal peripherals for use with an apparatus for detection of target protein-allosteric modulator interactions.

81 . The kit of claim 80 , wherein the one or more SHG or SFG-active labels are selected from the group consisting of maleimide labels, PyMPO-NHS, oxazole labels, BADAN (6-Bromoacetyl-2-Dimethylaminonaphthalene), ACRYLODAN™ (6-Acryloyl-2-Dimethylaminonaphthalene), and coumarin-based dyes.

82 . The kit of claim 80 , wherein the surface for binding a target protein is selected from the group consisting of glass, plastic, metal, latex, rubber, ceramic, and polymer.

83 . The kit of claim 81 , wherein the polymer is polypropylene, polyvinylidene difluoride, polystyrene, or polyethylene.

84 . The kit of claim 80 , wherein the surface for binding a target protein comprises at least one preformed surface feature.

85 . The kit of claim 84 , wherein the at least one preformed surface feature is a trench, a v-groove, a mesa structure, and/or a well.

86 . The kit of claim 80 , wherein the surface for binding a target protein is pre-coated with one or more molecules which provide a surface chemistry suitable for attachment to a target protein.

87 . The kit of claim 86 , wherein the one or more molecules are aldehyde silanes, BSA-NHS, or oligo-polyethylene glycol.

88 . The kit of claim 87 , wherein the oligo-polyethylene glycol is nickel-oligo-polyethylene glycol.

89 . The kit of claim 80 , wherein the surface for binding a target protein is pre-coated with a supported lipid bilayer or supported lipid analog bilayer.

90 . The kit of claim 80 , wherein the signal peripheral for use with an apparatus for detection of target protein-allosteric modulator interactions is a pass-filter, a color filter, an interference filter, a polarizing optic, or one or more mirrors or lenses for directing and focusing a beam.

91 . The kit of claim 80 , wherein the co-factor necessary for target protein functionality is thiamine pyrophosphate, NAD + , NADP + , pyridoxal phosphate, lipoamide, methylcobalamin, cobalamine, biotin, Coenzyme A, tetrahydrofolic acid, menaquinone, ascorbic acid, flavin mononucleotide, flavin adenine dinucleotide, Coenzyme F420, adenosine triphosphate (ATP), guanosine triphosphate (GTP), S-adenosyl methionine, Coenzyme B Coenzyme M, Coenzyme Q, cytidine triphosphate, glutathione, heme, nucleotide sugars, pyrroloquinoline, quinone, or tetrahydrobiopterin.

92 . A system for using a non-linear optical technique to screen for and identify agents which bind to and modulate allosteric sites on target proteins, the system comprising:

a. a target protein labeled with a non-linear-active moiety; and

b. an apparatus for detection of target protein-agent interactions, the apparatus comprising i) a source of fundamental light; ii) a substrate comprising the target protein labeled with a non-linear-active moiety, and iii) a detector for measuring a property of light generated by a nonlinear transformation of the fundamental light,

wherein binding of the agent to an allosteric site on the target protein results in a change in the property of the light generated by the non-linear transformation and is detected by the apparatus.

93 - 107 . (canceled)

108 . The system of claim 92 , wherein the non-linear transformation comprises second harmonic generation (SHG), sum frequency generation (SFG), or difference frequency generation (DFG).

109 . The system of claim 92 , wherein the non-linear-active moiety comprises a second harmonic-active, sum frequency-active, or difference frequency-active moiety.

110 . The system of claim 92 , wherein the target protein is selected from the group consisting of a G protein-coupled receptor, a steroid hormone receptor, or a tyrosine kinase receptor.

111 . The system of claim 92 , wherein the non-linear active moiety is selected from the group consisting of PyMPO maleimide, PyMPO-NHS, PyMPO-succinimidyl ester, Badan, and Acrylodan.

112 . The system of claim 92 , wherein the source of the fundamental light is a laser.

113 . The system of claim 92 , wherein the substrate is made of silica, glass, silicon, polystyrene, polycarbonate, nylon, a plastic, a metal, a semiconductor, or an insulator.

114 . The system of claim 92 , wherein the substrate further comprises a supported lipid phospholipid bilayer.

115 . The system of claim 92 , wherein the detector is a photomultiplier tube (PMT), photodiode, avalanche photodiode, or CCD detector.

116 . The system of claim 92 , wherein the apparatus further comprises a computer and software for controlling illumination of the target protein with the fundamental light and measuring the property of the light generated by a nonlinear transformation of the fundamental light, or changes thereof, upon contacting the surface-attached target protein with a ligand known to bind to an active site of the target protein, and (i) an allosteric modulator of the target protein, or (ii) a candidate allosteric modulator of the target protein.

117 . The system of claim 92 , wherein the property of the light generated by the non-linear transformation is intensity, wavelength, or polarization.

118 . The system of claim 92 , wherein the agent is a small molecule, an antibody, a non-antibody polypeptide, a carbohydrate, or an inhibitory nucleic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BLUELIGHT THERAPEUTICS, INC.
To: QUANTA THERAPEUTICS, INC.
Reel/Frame 057721/0206 →
CHANGE OF NAME Recorded Jun 24, 2020
From: BIODESY, INC.
To: BLUELIGHT THERAPEUTICS, INC.
Reel/Frame 053834/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2016
From: SALAFSKY, JOSHUA S.
To: BIODESY, INC.
Reel/Frame 038995/0600 →